Nephrotrans (Sodium Hydrogen Carbonate)

Sodium hydrogen carbonate, the active ingredient in Nephrotrans, is an antacid presented as an oral formulation for oral use and is marketed across the European Union. It neutralizes excess gastric acid and helps correct metabolic acidosis, making it useful for patients with acid indigestion, metabolic acidosis, or renal tubular acidosis.

GNH USA supplies Nephrotrans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Nephrotrans, an antacid, is employed to manage conditions where excess acid is present in the gastrointestinal tract or systemic circulation.

- Acid indigestion: provides rapid relief of heartburn and dyspeptic discomfort by neutralizing gastric acid. - Metabolic acidosis: supplies bicarbonate ions that raise systemic pH, assisting correction of acid‑base imbalance. - Renal tubular acidosis: helps restore urinary and plasma bicarbonate levels, supporting renal acid excretion.

Sodium hydrogen carbonate is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Nausea: mild stomach upset. - Belching: increased gas from carbon dioxide. - Abdominal discomfort: transient bloating. - Diarrhea: loose stools at higher doses.

Serious or Rare Side Effects: - Metabolic alkalosis: excessive blood pH elevation. - Severe hypernatremia: high sodium causing neurological signs. - Anaphylaxis: rare severe allergic reaction.

When using Nephrotrans, certain precautions should be observed to minimize risks and ensure safe therapy.

- Assess renal function: monitor serum creatinine and electrolyte levels before and during treatment. - Evaluate cardiac status: avoid in patients with congestive heart failure or fluid overload risk. - Review concomitant acid‑suppressing agents: adjust dosing if used together with proton‑pump inhibitors or H2 blockers. - Use caution in pregnancy: limited data; benefits must outweigh potential risks. - Monitor serum electrolytes: watch for hypernatremia, hypokalemia, and metabolic alkalosis. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Sodium hydrogen carbonate can alter the absorption or activity of several medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Digoxin: increased risk of toxicity due to altered potassium balance. - Lithium: reduced renal clearance may lead to lithium toxicity. - Tetracycline antibiotics: decreased absorption and reduced efficacy.

Moderate Interactions (Monitor Closely): - ACE inhibitors: potential for metabolic alkalosis. - NSAIDs: may impair renal excretion of bicarbonate. - Loop diuretics: increased risk of hypokalemia.